Amazfit’s much-hyped budget Garmin rival has built-in music storage and claims three-week battery life

Amazfit has launched the Active Max, a sports-focused smartwatch priced at £169 / $170 / €169.90 positioned as a budget rival to premium Garmin and Apple models. Key specs include a 1.5-inch 480x480 60Hz AMOLED (up to 3,000 nits), 658mAh battery with up to 25 days typical use (13 days heavy use, 64 hours GPS), 4GB onboard music storage, offline topographic/ski maps, GNSS chipset, PPG heart-rate, SpO2 and temperature sensors, NFC and Bluetooth 5.3. The aggressive feature-to-price positioning could intensify competition in the lower-priced wearable segment and attract price-sensitive consumers replacing higher-margin incumbents.

Analysis

Market structure: The Active Max (~$170) materially undercuts premium GPS-running watches (Garmin Forerunner/Forerunner-class at >$400), creating immediate price pressure in the mass endurance segment. Winners: Zepp/Amazfit (budget OEMs), GNSS/chip suppler Airoha, and retail channels that sell volume; losers: GRMN (direct ASP/mix hit) and, to a lesser extent, AAPL if Apple Watch sees migration at lower price sensitivity. Expect a 3–8% share shift in the casual/entry endurance market within 6–12 months, compressing Garmin’s wearable growth and ASPs unless it rebundles services or cuts prices.

Risk assessment: Tail risks include IP litigation or a regulator targeting bundled health-data features, and Airoha/component sanctions or shortages that could stall Amazfit shipments; operational execution (firmware, mapping accuracy) is another knock-on risk. Time horizons: immediate (0–30 days) — January sell-through and reviews will set tone; short-term (1–3 months) — channel inventory and Garmin guidance; long-term (12–24 months) — ecosystem stickiness and services revenue determine sustainable share. Hidden dependencies: Amazfit’s ability to monetize services (payments, AI coaching) and maintain firmware/OTA support.

Trade implications: Direct plays — establish a 2–3% long position in ZEPP (Amazfit’s parent) for a 6–12 month horizon, target 30–50% upside if sell-through exceeds expectations; initiate a 1–2% short or buy 3-month 15% OTM puts on GRMN expecting 10–20% downside on ASP erosion. Pair trade — long ZEPP / short GRMN to isolate competitive transfer risk. Options — prefer limited-risk structures: 3-month bear put spread on GRMN (−10%/−20% strikes) and a low-cost 90-day call spread on ZEPP; time entries now and scale in 25% tranches.

Contrarian angles: Consensus underestimates software/service stickiness — Garmin’s CIQ ecosystem and running metrics could retain serious athletes, limiting long-term share loss; conversely, Amazfit’s razor-thin margins may force discounting and poor user experience, reversing initial traction. Historical parallel: mid-2010s budget smartphone entrants grabbed volume but not high-margin share; outcome depended on services monetization. Actionable guardrails: stop-loss at 20% on ZEPP longs, exit GRMN shorts if guidance cites resilient pro-segment demand or ASP recovery within 60 days.

Key Decisions for Investors

• Establish a 2–3% long position in Zepp Health (ZEPP) with a 6–12 month horizon, target +30–50% upside if January–March sell-through and Amazon/retailer reviews are positive; set a hard stop-loss at −20%.
• Initiate a 1–2% short on Garmin (GRMN) via either equity or buy 3‑month 15% OTM puts; if preferring defined risk, use a 3‑month bear put spread (−10%/−20% strikes) sizing for 1% portfolio exposure and target 10–20% downside within 90 days.
• Execute a pair trade: long ZEPP (1.5–2%) funded by short GRMN (1–1.5%) to isolate competitive risk; scale positions in 25% increments over 30 days and reassess after Q1 sell-through data.
• Sell a 90‑day covered-call tranche on AAPL representing 1% portfolio exposure to harvest premium while trimming upside exposure; target strikes ~5–7% OTM given limited negative impact and to monetize near-term idiosyncratic risk.
• Monitor three catalysts closely over the next 30–60 days before increasing size: (1) Amazon/retailer sell-through and review-weighted rating >4.0 within 30 days; (2) Garmin quarterly revenue/ASP guidance — downgrade momentum if wearables ASP falls >5% QoQ; (3) any supply/firmware failures reported in >5% of early units — pause accumulation if true.